American Diabetes Association
Browse

Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II

Download (212.96 kB)
figure
posted on 2022-01-18, 23:50 authored by Rory H. Maclean, Peter Jacob, Pratik Choudhary, Simon R. Heller, Elena Toschi, Dulmini Kariyawasam, Augustin Brooks, Mike Kendall, Nicole de Zoysa, Linda A. Gonder-Frederick, Stephanie A. Amiel
Objectives: The Hypoglycemia Fear Survey II (HFS-II) is a well-validated measure of fear of hypoglycemia in people with type 1 diabetes. The aim of this study was to explore the relationships between hypoglycemia worries, behaviors, and cognitive barriers to hypoglycemia avoidance and hypoglycemia awareness status, severe hypoglycemia, and HbA1c.

Research design and methods: Participants with type 1 diabetes (n=178), enriched for people at risk of severe hypoglycemia (49%), completed questionnaires assessing hypoglycemia fear (HFS-II), hyperglycemia avoidance (HAS), diabetes distress (PAID), and cognitive barriers to hypoglycemia avoidance (A2A). Exploratory factor analysis was applied to the HFS-II. Clusters based on HFS-II, A2A, Gold, HAS and PAID were sought using k-means clustering.

Results: Four HFS-II factors were identified: Sought Safety, Restricted Activity, Ran High and Worry. Whilst Sought Safety, Restricted Activity and Worry increased with progressively impaired awareness and recurrent severe hypoglycemia, Ran High did not. Cluster analysis outlined four clusters: two clusters with preserved hypoglycemia awareness were differentiated by low fear / low cognitive barriers to hypoglycemia avoidance (cluster 1), versus high fear and distress and increased Ran High behaviors (cluster 2). Two clusters with impaired hypoglycemia awareness were differentiated by low fear / high cognitive barriers (cluster 3), and high fear / low cognitive barriers (cluster 4).

Conclusion: This is the first study to define clusters of hypoglycemia experience by worry, behaviors, and cognitive barriers to hypoglycemia avoidance. The resulting subtypes may be important in understanding and treating problematic hypoglycemia.

Funding

The study was funded by the Juvenile Diabetes Research Foundation Project Grant no 4- SRA-2017-266-M-N, with additional support from the UK’s National Institute of Health Research (NIHR) through the South London Collaboration for Leadership in Applied Health Research and Care South London (CLAHRC) at King's College Hospital NHS Foundation Trust, London, UK. The study is sponsored jointly by King’s College London (Professor Rezavi, susan.dickson@kcl.ac.uk) and King’s College Hospital NHS Foundation Trust, (Research & Innovation Office, kch-tr.research@nhs.net). The funders had no role in the design, conduct or analysis of this study. The views expressed are those of the authors and not necessarily those of the Juvenile Diabetes Research Foundation International (JDRF), the NHS, the NIHR or the Department of Health and Social Care.

History

Usage metrics

    Diabetes Care

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC